Brief: Lilly Announces Receipt Of NRC Consent In Connection With Its Proposed Acquisition Of Point Biopharma

POINT Biopharma Global

14/11/2023 22:28

Nov 14 (Reuters) - Eli Lilly and Co  LLY.N :
    * LILLY ANNOUNCES THE RECEIPT OF NRC CONSENT IN CONNECTION
WITH
ITS PROPOSED ACQUISITION OF POINT BIOPHARMA

Source text for Eikon:  ID:nPn9kxb0Qa 
Further company coverage:  LLY.N 

 ((reuters.briefs@thomsonreuters.com;))